{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:57:21Z","timestamp":1781017041885,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer cells with a less differentiated stem-like phenotype are more resistant to therapeutic manipulations than their differentiated counterparts, and are considered as one of the main causes of cancer persistence and relapse. As such, induction of differentiation in cancer stem-like cells (CSLCs) has emerged as an alternative strategy to enhance the efficacy of anticancer therapies. CSLCs are metabolically distinct from differentiated cells, and any aberration from the intrinsic metabolic state can induce differentiation of CSLCs. Therefore, metabolism-related molecular targets, with a capacity to promote differentiation within CSLCs, are of therapeutic importance. Here, we demonstrate that phosphoglycerate dehydrogenase (PHGDH), an essential enzyme catalyzing the synthesis of amino acid serine, is important for maintaining the poorly differentiated, stem-like state of CSLCs. Our data shows that PHGDH deficiency impairs the tumorsphere formation capacity in embryonal carcinoma stem-like cells (ECSLCs), breast cancer stem-like cells (BCSLCs) and patient-derived brain tumor-initiating cells (BTICs), which is accompanied by the reduced expression of characteristic stemness-promoting factors, such as Oct4, Nanog, Sox-2, and Bmi-1. Mechanistically, PHGDH deficiency in ECSLCs promotes differentiation to various lineages via degradation of Oct4 and by increasing the stability of differentiation marker \u03b23-tubulin. Furthermore, PHGDH inhibition promotes p-mTOR independent but Beclin-1-dependent autophagy, independent of apoptosis. When studied in combination, the inhibition of both PHGDH and p-mTOR in ECSLCs causes further augmentation of autophagy, and additionally promotes apoptosis, demonstrating the clinical applicability of PHGDH-based manipulations in cancer therapies. Recapitulating these in vitro findings in CSLC models, the intratumoral PHGDH expression in patient-derived tumors is positively correlated with the mRNA levels of stemness factors, especially Oct4, and cancer patients co-expressing high levels of PHGDH and Oct4 display significantly lower survival than those with low PHGDH\/Oct4 co-expression. Altogether, this study identifies a clinically-relevant role for PHGDH in the regulation of stemness-differentiation axis within CSLCs.<\/jats:p>","DOI":"10.1038\/s41419-018-0997-8","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:10:05Z","timestamp":1537780205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Tanveer","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Martell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saleh","family":"Ghassemi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-8941","authenticated-orcid":false,"given":"Ian C. G.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Gujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"997_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"997_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297\u2013308 (2012).","journal-title":"Cancer Cell"},{"key":"997_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang, M. & Vousden, K. H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16, 650\u2013662 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"997_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nchembio.2086","volume":"12","author":"C Frezza","year":"2016","unstructured":"Frezza, C. Cancer metabolism: addicted to serine. Nat. Chem. Biol. 12, 389\u2013390 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"997_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"key":"997_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869\u2013874 (2011).","journal-title":"Nat. Genet."},{"key":"997_CR7","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang, B. et al. PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep. 19, 2289\u20132303 (2017).","journal-title":"Cell Rep."},{"key":"997_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313\u2013319 (2011).","journal-title":"Nat. Med."},{"key":"997_CR9","doi-asserted-by":"crossref","first-page":"39550","DOI":"10.18632\/oncotarget.6098","volume":"6","author":"Z Huang","year":"2015","unstructured":"Huang, Z., Wu, T., Liu, A. Y. & Ouyang, G. Differentiation and transdifferentiation potentials of cancer stem cells. Oncotarget 6, 39550\u201339563 (2015).","journal-title":"Oncotarget"},{"key":"997_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell. Stem. Cell. 1, 313\u2013323 (2007).","journal-title":"Cell. Stem. Cell."},{"key":"997_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756\u2013760 (2006).","journal-title":"Nature"},{"key":"997_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.stem.2017.02.003","volume":"20","author":"D Chen","year":"2017","unstructured":"Chen, D. et al. Targeting BMI1+ cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell 20, 621\u2013634.e6 (2017).","journal-title":"Cell Stem Cell"},{"key":"997_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"997_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704\u2013715 (2008).","journal-title":"Cell"},{"key":"997_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta, P. B. et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645\u2013659 (2009).","journal-title":"Cell"},{"key":"997_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"997_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499\u2013507 (2008).","journal-title":"Nat. Genet."},{"key":"997_CR18","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/onc.2009.500","volume":"29","author":"S Peng","year":"2010","unstructured":"Peng, S., Maihle, N. J. & Huang, Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29, 2153\u20132159 (2010).","journal-title":"Oncogene"},{"key":"997_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","volume":"167","author":"DB Sykes","year":"2016","unstructured":"Sykes, D. B. et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia. Cell 167, 171\u2013186 e115 (2016).","journal-title":"Cell"},{"key":"997_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.stem.2014.04.007","volume":"15","author":"Z Zhu","year":"2014","unstructured":"Zhu, Z. et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell 15, 185\u2013198 (2014).","journal-title":"Cell Stem Cell"},{"key":"997_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nature16187","volume":"529","author":"L Garcia-Prat","year":"2016","unstructured":"Garcia-Prat, L. et al. Autophagy maintains stemness by preventing senescence. Nature 529, 37\u201342 (2016).","journal-title":"Nature"},{"key":"997_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/15548627.2016.1260808","volume":"13","author":"T Sharif","year":"2017","unstructured":"Sharif, T. et al. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy 13, 264\u2013284 (2017).","journal-title":"Autophagy"},{"key":"997_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature21388","volume":"543","author":"TT Ho","year":"2017","unstructured":"Ho, T. T. et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature 543, 205\u2013210 (2017).","journal-title":"Nature"},{"key":"997_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1535-7163.MCT-10-0606","volume":"10","author":"R Tripathi","year":"2011","unstructured":"Tripathi, R., Samadder, T., Gupta, S., Surolia, A. & Shaha, C. Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Mol. Cancer Ther. 10, 255\u2013268 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"997_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molcel.2012.08.030","volume":"48","author":"Y Lin","year":"2012","unstructured":"Lin, Y. et al. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol. Cell 48, 627\u2013640 (2012).","journal-title":"Mol. Cell"},{"key":"997_CR26","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1158\/1078-0432.CCR-14-3147","volume":"21","author":"C Venugopal","year":"2015","unstructured":"Venugopal, C. et al. Pyrvinium targets CD133 in human glioblastoma brain tumor-initiating cells. Clin. Cancer Res. 21, 5324\u20135337 (2015).","journal-title":"Clin. Cancer Res."},{"key":"997_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"997_CR28","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1158\/0008-5472.CAN-16-0530","volume":"76","author":"D Samanta","year":"2016","unstructured":"Samanta, D. et al. PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis. Cancer Res. 76, 4430\u20134442 (2016).","journal-title":"Cancer Res."},{"key":"997_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.scr.2011.09.008","volume":"8","author":"C Venugopal","year":"2012","unstructured":"Venugopal, C. et al. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells. Stem Cell Res. 8, 141\u2013153 (2012).","journal-title":"Stem Cell Res."},{"key":"997_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.stem.2015.05.008","volume":"17","author":"JC Larsimont","year":"2015","unstructured":"Larsimont, J. C. et al. Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion. Cell Stem Cell 17, 60\u201373 (2015).","journal-title":"Cell Stem Cell"},{"key":"997_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"997_CR32","first-page":"2244","volume":"63","author":"LH Looijenga","year":"2003","unstructured":"Looijenga, L. H. et al. POU5F1 (OCT3\/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63, 2244\u20132250 (2003).","journal-title":"Cancer Res."},{"key":"997_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2559.2005.02182.x","volume":"47","author":"CE Hoei-Hansen","year":"2005","unstructured":"Hoei-Hansen, C. E. et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 47, 48\u201356 (2005).","journal-title":"Histopathology"},{"key":"997_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/74199","volume":"24","author":"H Niwa","year":"2000","unstructured":"Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3\/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372\u2013376 (2000).","journal-title":"Nat. Genet."},{"key":"997_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1634\/stemcells.22-2-225","volume":"22","author":"DC Hay","year":"2004","unstructured":"Hay, D. C., Sutherland, L., Clark, J. & Burdon, T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22, 225\u2013235 (2004).","journal-title":"Stem Cells"},{"key":"997_CR36","doi-asserted-by":"publisher","first-page":"369828","DOI":"10.1155\/2015\/369828","volume":"2015","author":"CA Piccinato","year":"2015","unstructured":"Piccinato, C. A., Sertie, A. L., Torres, N., Ferretti, M. & Antonioli, E. High OCT4 and Lowp16(INK4A) expressions determine in vitro lifespan of mesenchymal stem cells. Stem Cells Int. 2015, 369828 (2015).","journal-title":"Stem Cells Int."},{"key":"997_CR37","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J. & Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798\u20131806 (2009).","journal-title":"Nat. Protoc."},{"key":"997_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"997_CR39","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1101\/gad.995802","volume":"16","author":"DC Fingar","year":"2002","unstructured":"Fingar, D. C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E. Genes Dev. 16, 1472\u20131487 (2002).","journal-title":"Genes Dev."},{"key":"997_CR40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"997_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251\u2013262 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"997_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"997_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2012.12.016","volume":"152","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290\u2013303 (2013).","journal-title":"Cell"},{"key":"997_CR44","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.4161\/auto.7068","volume":"4","author":"F Scarlatti","year":"2008","unstructured":"Scarlatti, F., Maffei, R., Beau, I., Ghidoni, R. & Codogno, P. Non-canonical autophagy: an exception or an underestimated form of autophagy? Autophagy 4, 1083\u20131085 (2008).","journal-title":"Autophagy"},{"key":"997_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111\u2013115 (2007).","journal-title":"Nature"},{"key":"997_CR46","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"997_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/bjc.2016.152","volume":"114","author":"P Sancho","year":"2016","unstructured":"Sancho, P., Barneda, D. & Heeschen, C. Hallmarks of cancer stem cell metabolism. Br. J. Cancer 114, 1305\u20131312 (2016).","journal-title":"Br. J. Cancer"},{"key":"997_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.stem.2010.11.015","volume":"7","author":"S Zhu","year":"2010","unstructured":"Zhu, S. et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell. Stem. Cell. 7, 651\u2013655 (2010).","journal-title":"Cell. Stem. Cell."},{"key":"997_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","volume":"23","author":"CL Chen","year":"2016","unstructured":"Chen, C. L. et al. NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism. Cell. Metab. 23, 206\u2013219 (2016).","journal-title":"Cell. Metab."},{"key":"997_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/15384101.2014.974419","volume":"14","author":"YA Shen","year":"2015","unstructured":"Shen, Y. A., Wang, C. Y., Hsieh, Y. T., Chen, Y. J. & Wei, Y. H. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle 14, 86\u201398 (2015).","journal-title":"Cell Cycle"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0997-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0997-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:18:06Z","timestamp":1671538686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0997-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["997"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0997-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"990"}}